SuperworthTelomir Pharmaceuticals market cap TELO
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $67.1M
- Highest close in our data
- $266.5M
- Apr 2024
Telomir Pharmaceuticals is worth $67.1M at the close on Oct 23, 2026, at $0.98 a share.
That is up 38% over the last year.
Its highest close in our data was $266.5M in Apr 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $67.1M | $37.5M | $97.7M | +34% |
| 2025 | $50.2M | $34.2M | $148.9M | −65% |
| 2024 | $144.2M | $98.9M | $266.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Telomir Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| TELOTelomir Pharmaceuticals | $67.1M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| Peer median | $477.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Telomir Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.